News

Boult Wade Tennant ranked top tier for Trade Marks in MIP’s IP Stars, 2018

Boult Wade Tennant is delighted to announce our Trade Mark practice has once again been recognised by Managing Intellectual Property IP Stars

The Biotechnology and Life Sciences group discuss CRISPR with Biotech and Money

Patent Attorney Edward Ronan and Trainee Patent Attorney Nadia Tyler-Rubinstein cover the latest developments in the case against CRISPR with Biotech and

Boult Wade Tennant awarded top tier status by WTR 1000 2018

A great start to the new year for Boult Wade Tennant with our trade mark practice being recognised as a top tier

Patent Attorney featured in latest edition of the CIPA Journal

Boult Wade Tennant Patent Attorney in London Matthew Ridley has contributed to the latest edition of the CIPA Journal. His article entitled

Partners James Short and Rohan Setna discuss EPO oppositions and appeals in The Patent Law Litigation Review

Engineering and Designs practice group partner James Short, and Chemical and Materials practice group partner Rohan Setna have contributed to the recently

Partner Nina White and Attorney Edward Ronan talk to Biotech and Money

Head of our Biotechnology and Life Sciences Patent group Nina White, and Patent Attorney Edward Ronan were recently interviewed by Biotech and

Boult Wade Tennant tops 2018 Chambers and Partners ranking for another consecutive year

We are very pleased to announce the firm has been awarded Band One status by Chambers and Partners in the 2018 Intellectual

New Partner announcement – November 2017

We are delighted to announce the promotion of Susi Fish to Partner, effective as of 1 November 2017. Susi joined the firm

Boult Wade Tennant ranked Tier One by Legal 500 UK for 12th consecutive year

Boult Wade Tennant are proud to announce the firm has been ranked in the top tier by Legal 500 UK, in both

Partner Jennifer O’Farrell provides commentary on Actavis UK Ltd and others v Eli Lilly and Company decision

Biotechnology and Life Sciences practice group Partner Jennifer O’Farrell has recently provided commentary on landmark decision by the UK Supreme court on